Total Payments
$42,940
2024 Payments
$7,114
Companies
23
Transactions
127
Medicare Patients
522
Medicare Billing
$76,696

Payment Breakdown by Category

Consulting$33,842 (78.8%)
Other$3,445 (8.0%)
Food & Beverage$3,087 (7.2%)
Travel$2,511 (5.8%)
Education$55.75 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $33,842 11 78.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,445 2 8.0%
Food and Beverage $3,087 104 7.2%
Travel and Lodging $2,511 7 5.8%
Education $55.75 3 0.1%

Top Paying Companies

Company Total Records Latest Year
Genentech USA, Inc. $15,665 52 $0 (2024)
Biogen, Inc. $14,363 23 $0 (2024)
F. Hoffmann-La Roche AG $6,408 7 $0 (2024)
Alexion Pharmaceuticals, Inc. $2,083 3 $0 (2024)
ROCHE DIAGNOSTICS INTERNATIONAL LTD $1,925 1 $0 (2023)
TG Therapeutics, Inc. $1,682 4 $0 (2024)
Amgen Inc. $134.52 3 $0 (2024)
Genentech, Inc. $131.89 2 $0 (2024)
Celgene Corporation $131.86 5 $0 (2024)
Novartis Pharmaceuticals Corporation $96.56 7 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,114 35 F. Hoffmann-La Roche AG ($6,408)
2023 $3,762 14 ROCHE DIAGNOSTICS INTERNATIONAL LTD ($1,925)
2022 $2,342 20 Alexion Pharmaceuticals, Inc. ($2,066)
2021 $5,455 15 Genentech USA, Inc. ($5,419)
2020 $1,635 7 Genentech USA, Inc. ($1,589)
2019 $11,317 16 Biogen, Inc. ($7,005)
2018 $11,316 20 Biogen, Inc. ($7,232)

All Payment Transactions

127 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/18/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $20.44 General
Category: Inflammation/Rare Disease
12/17/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $98.12 General
Category: Inflammation/Rare Disease
12/12/2024 Abbott Laboratories INFINITY (Device) Food and Beverage In-kind items and services $24.97 General
Category: Neuromodulation
12/11/2024 Biogen, Inc. TYSABRI (Biological), VUMERITY Food and Beverage In-kind items and services $19.16 General
Category: Neurology
12/04/2024 Genentech USA, Inc. Ocrevus Zunovo (Biological) Food and Beverage In-kind items and services $16.73 General
Category: Immunology
11/12/2024 Biogen, Inc. TYSABRI (Biological), VUMERITY Food and Beverage In-kind items and services $27.21 General
Category: Neurology
11/06/2024 Genentech USA, Inc. Ocrevus Zunovo (Biological) Food and Beverage In-kind items and services $13.42 General
Category: Immunology
10/30/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $18.99 General
Category: Neuroscience
10/16/2024 Biogen, Inc. TYSABRI (Biological), VUMERITY Food and Beverage In-kind items and services $14.04 General
Category: Neurology
10/02/2024 Genentech USA, Inc. Ocrevus (Biological), Ocrevus Zunovo Food and Beverage In-kind items and services $17.00 General
Category: Immunology
09/24/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $23.75 General
Category: Neuroscience
09/19/2024 TG Therapeutics, Inc. BRIUMVI (Drug) Food and Beverage In-kind items and services $33.97 General
Category: Immunology
09/16/2024 F. Hoffmann-La Roche AG Ocrevus (Biological) Consulting Fee Cash or cash equivalent $2,070.00 General
Category: Immunology
09/16/2024 F. Hoffmann-La Roche AG Ocrevus (Biological) Travel and Lodging Cash or cash equivalent $676.40 General
Category: Immunology
09/16/2024 F. Hoffmann-La Roche AG Ocrevus (Biological) Travel and Lodging Cash or cash equivalent $251.63 General
Category: Immunology
09/16/2024 F. Hoffmann-La Roche AG Ocrevus (Biological) Travel and Lodging Cash or cash equivalent $68.14 General
Category: Immunology
09/16/2024 F. Hoffmann-La Roche AG Ocrevus (Biological) Food and Beverage In-kind items and services $64.60 General
Category: Immunology
09/10/2024 Biogen, Inc. TYSABRI (Biological), VUMERITY Food and Beverage In-kind items and services $22.37 General
Category: Neurology
09/04/2024 Genentech USA, Inc. Ocrevus (Biological) Food and Beverage In-kind items and services $14.16 General
Category: Immunology
08/29/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $14.50 General
Category: Central Nervous System
08/14/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $21.19 General
Category: General - DBS_NMD
08/07/2024 Genentech USA, Inc. Enspryng (Biological), Ocrevus Food and Beverage In-kind items and services $15.79 General
Category: Immunology
08/06/2024 Biogen, Inc. VUMERITY (Drug) Food and Beverage In-kind items and services $17.00 General
Category: Neurology
07/18/2024 ABBVIE INC. DUOPA (Drug) Food and Beverage In-kind items and services $14.73 General
Category: NEUROSCIENCE
07/10/2024 Biogen, Inc. TYSABRI (Biological) Food and Beverage In-kind items and services $25.12 General
Category: Neurology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 99 149 $124,128 $18,941
2022 2 116 163 $108,625 $20,034
2021 2 112 165 $99,401 $21,924
2020 5 195 236 $58,735 $15,796
Total Patients
522
Total Services
713
Medicare Billing
$76,696
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 83 129 $112,053 $17,328 15.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 16 20 $12,075 $1,613 13.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 74 111 $81,705 $15,996 19.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 42 52 $26,920 $4,038 15.0%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 74 123 $80,309 $18,166 22.6%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 38 42 $19,092 $3,759 19.7%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 51 64 $19,456 $5,623 28.9%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 44 53 $21,518 $5,039 23.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 58 77 $16,093 $4,636 28.8%
92133 Diagnostic imaging of optic nerve of eye Office 2020 13 13 $1,378 $441.24 32.0%
96160 Administration and interpretation of patient-focused health risk assessment Office 2020 29 29 $290.00 $56.79 19.6%

About Matthew Tremblay, M.D., PH.D

Matthew Tremblay, M.D., PH.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Livingston, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2011. The National Provider Identifier (NPI) number assigned to this provider is 1720379845.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Matthew Tremblay, M.D., PH.D has received a total of $42,940 in payments from pharmaceutical and medical device companies, with $7,114 received in 2024. These payments were reported across 127 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($33,842).

As a Medicare-enrolled provider, Tremblay has provided services to 522 Medicare beneficiaries, totaling 713 services with total Medicare billing of $76,696. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

Products in Payments

  • OCREVUS (Biological) $15,374
  • TYSABRI (Biological) $7,340
  • Ocrevus (Biological) $6,692
  • ULTOMIRIS (Biological) $2,082
  • cobas 6800 System (Device) $1,925
  • BRIUMVI (Drug) $1,682
  • ZEPOSIA (Drug) $147.59
  • UPLIZNA (Biological) $134.52
  • Enspryng (Biological) $78.60
  • GILENYA (Drug) $51.25
  • Ocrevus Zunovo (Biological) $30.15
  • ACTHAR (Biological) $29.75
  • AUBAGIO (Drug) $28.86
  • INFINITY (Device) $24.97
  • KESIMPTA (Drug) $19.62
  • Xeomin (Biological) $19.14
  • PERCEPT PC BRAINSENSE (Device) $19.09
  • VUMERITY (Drug) $17.00
  • LEMTRADA (Drug) $15.90
  • Mavenclad (Drug) $15.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Livingston